Prayura Kunasol

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

Supachai Rerks‐Ngarm, Punnee Pitisuttithum, Sorachai Nitayaphan et al. · New England Journal of Medicine · 2009 · 3K citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +12

Impact of Thailand's HIV-control programme as indicated by the decline of sexually transmitted diseases

Robert Hanenberg, David C. Sokal, Wiwat Rojanapithayakorn et al. · The Lancet · 1994 · 436 citations

Public Health, Infectious Disease Control, Infectious Diseases +11

Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144

Merlin L. Robb, Supachai Rerks‐Ngarm, Sorachai Nitayaphan et al. · The Lancet Infectious Diseases · 2012 · 215 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

The Thai Phase III Trial (RV144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes within the V2 Region of HIV-1 Envelope

Mark de Souza, Silvia Ratto‐Kim, Weerawan Chuenarom et al. · The Journal of Immunology · 2012 · 140 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial

Supachai Rerks‐Ngarm, Punnee Pitisuttithum, Jean‐Louis Excler et al. · The Journal of Infectious Diseases · 2017 · 71 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17